Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 8, Pages 4263
Publisher
MDPI AG
Online
2021-04-21
DOI
10.3390/ijms22084263
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
- (2021) Silke Gillessen et al. JOURNAL OF CLINICAL ONCOLOGY
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma
- (2020) Jianyi Li et al. Biomed Research International
- Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
- (2020) Xi-Feng Jin et al. Cancers
- Safety, Efficacy and Biomarker Analysis of Toripalimab in previously treated advanced melanoma: results of the POLARIS-01 multicenter phase II trial
- (2020) Bixia Tang et al. CLINICAL CANCER RESEARCH
- Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers
- (2020) João Lobo et al. BMC CANCER
- Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness
- (2020) Silvia Schmidtova et al. Cancer Cell International
- WNT signalling in the normal human adult testis and in male germ cell neoplasms
- (2020) Julia C Young et al. HUMAN REPRODUCTION
- CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors
- (2020) Yu Chen et al. Frontiers in Immunology
- Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma
- (2020) RYOSUKE GABATA et al. ANTICANCER RESEARCH
- Impact of Wnt/β-Catenin Inhibition on Cell Proliferation through CDC25A Downregulation in Soft Tissue Sarcomas
- (2020) Esther Martinez-Font et al. Cancers
- New insights into germ cell tumor genomics
- (2019) J.T. Lafin et al. Andrology
- Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
- (2019) Jerry Harb et al. Current Oncology Reports
- Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells
- (2019) Robert Kleszcz et al. CELLULAR ONCOLOGY
- Phase II study of avelumab in multiple relapsed/refractory germ cell cancer
- (2019) M. Mego et al. INVESTIGATIONAL NEW DRUGS
- Genetic Aberrations in the CDK4 Pathway Are Associated with Innate Resistance to PD-1 Blockade in Chinese Patients with Non-Cutaneous Melanoma
- (2019) Jiayi Yu et al. CLINICAL CANCER RESEARCH
- Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
- (2019) Silvia Schmidtova et al. Cancers
- Wnt signaling and drug resistance in cancer
- (2019) Zheng Zhong et al. MOLECULAR PHARMACOLOGY
- Molecular mechanisms of resistance in testicular germ cell tumors – Clinical implications
- (2018) Katarina Kalavska et al. CURRENT CANCER DRUG TARGETS
- Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro
- (2018) Abigail Kora Suwala et al. Oncotarget
- Integrated Molecular Characterization of Testicular Germ Cell Tumors
- (2018) Hui Shen et al. Cell Reports
- Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group
- (2018) Martin Fenner et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors
- (2018) Silvia Schmidtova et al. Current Oncology Reports
- βcatenin is a marker of poor clinical characteristics and suppressed immune infiltration in testicular germ cell tumors
- (2018) Michal Chovanec et al. BMC CANCER
- Targeting the Wnt/β-catenin pathway in human osteosarcoma cells
- (2018) Fang Fang et al. Oncotarget
- Testicular cancer
- (2018) Liang Cheng et al. Nature Reviews Disease Primers
- High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience
- (2017) Nabil Adra et al. JOURNAL OF CLINICAL ONCOLOGY
- Current Management of Refractory Germ Cell Tumors and Future Directions
- (2017) J. Clayton Allen et al. Current Oncology Reports
- Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma
- (2017) Souvick Roy et al. CELLULAR ONCOLOGY
- Inhibition of porcupine prolongs metastasis free survival in a mouse xenograft model of Ewing sarcoma
- (2017) Masanori Hayashi et al. Oncotarget
- Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
- (2017) Kiminori Kimura et al. EBioMedicine
- The expression of SFRP1, SFRP3, DVL1, and DVL2 proteins in testicular germ cell tumors
- (2016) Dora Fabijanovic et al. APMIS
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2016) Holger Moch et al. EUROPEAN UROLOGY
- Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
- (2016) Aditya Bagrodia et al. JOURNAL OF CLINICAL ONCOLOGY
- In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model
- (2016) Shannon F. Rudy et al. Journal of Otolaryngology-Head & Neck Surgery
- β-catenin signaling pathway regulates cisplatin resistance in lung adenocarcinoma cells by upregulating Bcl-xl
- (2016) JIN ZHANG et al. Molecular Medicine Reports
- Wnt signaling in cancer
- (2016) T Zhan et al. ONCOGENE
- Phase II study of everolimus in refractory testicular germ cell tumors
- (2016) Michal Mego et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Platinum-refractory germ cell tumors: an update on current treatment options and developments
- (2016) Christoph Oing et al. WORLD JOURNAL OF UROLOGY
- Overexpression ofβ-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
- (2016) Long Li et al. Biomed Research International
- Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
- (2015) Z. Cierna et al. ANNALS OF ONCOLOGY
- Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells
- (2015) Samir H. Barghout et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interference with the Expression of β-Catenin Reverses Cisplatin Resistance in A2780/DDP Cells and Inhibits the Progression of Ovarian Cancer in Mouse Model
- (2015) Hongmin Zhao et al. DNA AND CELL BIOLOGY
- Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974
- (2015) Jonathan D Boone et al. LABORATORY INVESTIGATION
- Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
- (2015) Anil Belur Nagaraj et al. Oncotarget
- Safely targeting cancer stem cells via selective catenin coactivator antagonism
- (2014) Heinz-Josef Lenz et al. CANCER SCIENCE
- Cyclin D1 Amplification in Multiple Myeloma Is Associated With Multidrug Resistance Expression
- (2014) Eman M. Sewify et al. Clinical Lymphoma Myeloma & Leukemia
- Phase II Clinical Trial of Oxaliplatin and Bevacizumab in Refractory Germ Cell Tumors
- (2013) Amit Jain et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Extragonadal germ cell tumors
- (2013) Costantine Albany et al. CURRENT OPINION IN ONCOLOGY
- International Variations and Trends in Testicular Cancer Incidence and Mortality
- (2013) Ariana Znaor et al. EUROPEAN UROLOGY
- Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
- (2013) J. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Three decades of Wnts: a personal perspective on how a scientific field developed
- (2012) Roel Nusse et al. EMBO JOURNAL
- Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
- (2011) K. Oechsle et al. ANNALS OF ONCOLOGY
- Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors
- (2011) Karin Oechsle et al. EUROPEAN UROLOGY
- Down-Regulation of the Oncogene Cyclin D1 Increases Migratory Capacity in Breast Cancer and Is Linked to Unfavorable Prognostic Features
- (2010) Sophie Lehn et al. AMERICAN JOURNAL OF PATHOLOGY
- The Association of CCND1 Overexpression and Cisplatin Resistance in Testicular Germ Cell Tumors and Other Cancers
- (2010) Elodie E. Noel et al. AMERICAN JOURNAL OF PATHOLOGY
- TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis
- (2010) Darren R. Feldman et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin
- (2010) P. Stehlik et al. NEOPLASMA
- Loss of heterozygosity of selected tumor suppressor genes in human testicular germ cell tumors
- (2010) Tomislav Vladušić et al. PATHOLOGY RESEARCH AND PRACTICE
- Recent developments in testicular germ cell tumor research
- (2009) Gert-Jan M. van de Geijn et al. BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started